Skip to main content

Table 4 Leave-one-out sensitivity analysis of the association between PPARγ Pro12Ala polymorphism and DKD risk

From: The impact of PPARγ and ApoE gene polymorphisms on susceptibility to diabetic kidney disease in type 2 diabetes mellitus: a meta-analysis

Study omitted

Odds ratio

95% CI

Mohamed et al., 2022 [54]

0.73

0.61–0.86

Hashemian et al., 2021 [22]

0.73

0.61–0.87

Chen et al., 2020 [15]

0.76

0.64–0.90

Regine et al., 2020 [23]

0.74

0.61–0.89

Lapice et al., 2015 [16]

0.74

0.61–0.89

Bhaskar et al., 2013 [25]

0.75

0.63–0.90

Ahmed et al., 2013 [55]

0.75

0.63–0.89

Zhang et al., 2012 [17]

0.72

0.60–0.86

De cosmo 1 et al., 2011 [56]

0.71

0.60–0.85

De cosmo 2 et al., 2011 [56]

0.73

0.61–0.88

De cosmo 3 et al., 2011 [56]

0.73

0.60–0.88

Liu et al., 2010 [18]

0.77

0.65–0.92

Wu et al., 2009 [57]

0.74

0.61–0.89

De cosmo et al., 2009 [19]

0.76

0.64–0.90

Erdogan et al., 2007 [58]

0.74

0.62–0.88

Pollex et al., 2007 [59]

0.76

0.64–0.90

Stefanski et al., 2006 [60]

0.73

0.61–0.88

Caramori et al., 2003 [20]

0.76

0.63–0.90

Herrmann et al., 2002 [21]

0.73

0.61–0.89

Mori et al., 2001 [61]

0.72

0.60–0.86